142 related articles for article (PubMed ID: 10083050)
1. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart.
Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
Transplant Proc; 1999; 31(1-2):143-6. PubMed ID: 10083050
[No Abstract] [Full Text] [Related]
2. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation.
Hachida M; Lu H; Zhang X; Saito S; Furutani Y; Matsuoka R; Hoshi H; Koyanagi H
Transplant Proc; 1999 Nov; 31(7):2719-23. PubMed ID: 10578264
[No Abstract] [Full Text] [Related]
4. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
5. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
Maggard MA; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski JW; Busuttil RW; Imagawa DK
Transplant Proc; 1999; 31(1-2):728-9. PubMed ID: 10083311
[No Abstract] [Full Text] [Related]
6. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
[No Abstract] [Full Text] [Related]
7. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
Gannedahl G; Wanders A; Carlsson M; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
[No Abstract] [Full Text] [Related]
8. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.
Madsen JC; Yamada K; Allan JS; Choo JK; Erhorn AE; Pins MR; Vesga L; Slisz JK; Sachs DH
Transplantation; 1998 Feb; 65(3):304-13. PubMed ID: 9484744
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
Hisatomi K
Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
[No Abstract] [Full Text] [Related]
10. 15-deoxyspergualin effects in rat heart allograft transplantation--relation to dose, timing, and cyclosporine.
Gannedahl G; Wanders A; Carlsson M; Tufveson G
Transplantation; 1993 Feb; 55(2):455-6. PubMed ID: 8434408
[No Abstract] [Full Text] [Related]
11. The effects of heart/kidney versus double heart transplantation on tolerance induction and prevention of cardiac allograft vasculopathy.
Yamada K; Menard MT; Mawulawde K; Slisz JK; Choo JK; Erhorn AE; Sachs DH; Madsen JC
Transplant Proc; 1999; 31(1-2):108. PubMed ID: 10083032
[No Abstract] [Full Text] [Related]
12. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
[No Abstract] [Full Text] [Related]
13. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
[No Abstract] [Full Text] [Related]
14. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478
[No Abstract] [Full Text] [Related]
15. Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
Wahlers T; Mügge A; Oppelt P; Heublein B; Fieguth HG; Jurmann M; Haverich A
Transplant Proc; 1994 Oct; 26(5):2741-2. PubMed ID: 7940860
[No Abstract] [Full Text] [Related]
16. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
Ueda H; Itoh S; Kusaka M; Isurugi K
Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
[No Abstract] [Full Text] [Related]
17. New immunosuppressive agents in experimental allogeneic heart transplantation.
Walter P; Bernhard U; Menger M; Keller HE; Schorlemmer HU; Feifel G
Transplant Proc; 1990 Oct; 22(5):2324. PubMed ID: 2219388
[No Abstract] [Full Text] [Related]
18. Synergistic effects of 15-deoxyspergualin with cyclosporine and the TCR-targeted monoclonal antibody R73 to induce specific unresponsiveness to skin allografts in rats.
Schorlemmer HU; Dickneite G; Kurrle R; Seiler FR
Transplant Proc; 1995 Feb; 27(1):414-6. PubMed ID: 7879044
[No Abstract] [Full Text] [Related]
19. Synergistic interaction of 15-deoxyspergualin and cyclosporine to prolong the survival of rat islet allografts.
Gores PF; Field JF; Sutherland DE; Chou TC
Transplant Proc; 1994 Apr; 26(2):745. PubMed ID: 8171638
[No Abstract] [Full Text] [Related]
20. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
